Detailed client case studies will be published here as they are cleared for release. In the meantime, these are the Z2 engagements clients most often ask for – and the questions each one answers.
The question: Is our cell line strategy right for this molecule, and will the clone hold up?
The question: How do we raise titre and consistency, and will the process scale?
The question: Can the receiving site reproduce our process?
The question: What are the technical risks before we invest, partner or file?
The question: What does it take to stand up a working development lab?
The question: Are we ready – legally and practically – for GM work?
The question: Will our technical case stand up to funders and investors?
Have a similar challenge? Talk to us about your programme.
Whether you are designing a CLD programme, stuck on an upstream process, preparing for technology transfer, or assessing a biologics asset before you commit.
Call Anil
